In this concise video, review a synthesis of recommendations from AGA and ACG guidelines on the treatment of moderate to severe UC and CD, and hear expert discussion on the rationale for early induction therapy with a biologic.
Learn about current guideline recommendations for the treatment of moderate to severe UC and CD, including the rationale for combination therapy.
With advances in novel biologic and small molecule treatment options, new diagnostics, and increasingly complex treatment algorithms, STRIDE-II extends on the previous STRIDE recommendations to help define reasonable treatment targets for IBD.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.